Primary interest is Bio with intriguing pipelines that have large growth potential. I attempt to hold >50% of positions LT unless negative data, mgmt. concerns, or known negative events. Diversify and only trade in spec what you can lose.
Suttmeier, a former U.S. Treasury trader has more than 40 years of experience in the U.S. financial markets. Suttmeier is an engineer by education with a master of science degree. He has been writing newsletters and market commentaries since 1984,
Amigobulls specializes in technology stock analysis with a focus on video content. We provide great stock picks based on our proprietary analysis algorithm. If you have an opinion about a stock, become a contributor & start sharing ideas with videos.
Option trading headlines, breaking news, rumors and strategy. Nothing we post constitutes investment advice; we may have positions in mentioned names. Follow us on Twitter @Openoutcrier for real-time tweets and commentary
Long term investor with 20+ years in pharmaceutical industry and a focus on developmental biotech companies. Do your own DD before investing. My thoughts and posts are not investment advice...just my thoughts.